The Valens Company Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Retrieved on:
Monday, February 28, 2022
Depreciation, Risk, TSX, Health, Valens (company), Income, Compliance, Partnership, CBD, Financial statement, Growth, SEDAR, EBITDA, Cannabis, COVID-19, Company, Sale, Adjusted gross income, IFRS, Environment, Center, Conversation, Capital market, Corporate development, Fallows, Multimedia, Centre of Excellence for Operations in Confined and Shallow Waters, Green Road station, Intention, Disclosure, Nasdaq, Management, B2B, Forward-looking statement, Stock, Research, Bank, Online shopping, Risk management, Valens, Analysis
See reconciliation of "Adjusted EBITDA (non-GAAP measure)" in the Company's Management's Discussion and Analysis for the year ended November 30, 2021 (in addition to the period ended August 31, 2021).
Key Points:
- See reconciliation of "Adjusted EBITDA (non-GAAP measure)" in the Company's Management's Discussion and Analysis for the year ended November 30, 2021 (in addition to the period ended August 31, 2021).
- The call will be available via webcast on the Valens investor page of the Company website at https://thevalenscompany.com/investors/ or at this link .
- The Valens Company cautions you not to place undue reliance upon any such forward-looking statements.
- Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.